BioSpace News Archive

MorphoSys AG announced today that, in a press release issued today, its licensing partner GSK reported data from their phase 2 BAROQUE clinical study of GSK3196165 (formerly MOR103) in rheumatoid arthritis (RA). The study was conducted in patients with moderate to severe RA who had an inadequate response to methotrexate.

New data analyses highlight myelopreservation and immune system benefits of trilaciclib in combination with chemotherapy

Medtronic plc announced today that its co-founder, Earl E. Bakken, passed away peacefully on October 21, 2018 at his home on Kiholo Bay on the Big Island of Hawaii. He was 94 years old.

As part of a plan to lower prescription drug prices for millions of Americans, President Donald Trump is set to announce a sweeping plan to overhaul how Medicare pays for medication.

After releasing positive topline data from the Phase II study of BAN2401 as a potential treatment for Alzheimer’s disease in July, some of the numbers did not hold up. This morning Biogen and its developmental partner Eisai attempted to provide an update on the information to show that the anti-amyloid plaque treatment still has some life.

Recipharm today announces that it will continue the manufacturing operations at its facility in Höganäs, Sweden, operations that earlier were set towards being discontinued.

Data Show Vectra Test Is Correlated with Treatment Response

apceth Biopharma GmbH announced today positive results for apceth-201 in mouse models for acute graft-versus-host disease (aGvHD).

Retrophin, Inc. today announced it will report third quarter 2018 financial results on Thursday, November 1, 2018 after the close of the U.S. financial markets.

Immunicum AB (publ) in accordance with the principles of appointing the Nomination Committee, adopted by the Annual General Meeting of April 25, 2018, announced today that the members of the Nomination Committee have been appointed.